Motley Fool

There are a couple of big reasons why Moderna stock isn’t as good of a pick as Pfizer right now.

The meme stock was not immune to the broad market sell-off on Monday.

A host of issues plagued the EV pioneer.

This could be the best time to be greedy with these growth stocks.

The National Transportation Safety Board and other regulators raise concerns over Tesla’s Full Self-Driving software.

The controversial data mining firm still has a bright future.

“The Wall Street Journal” keeps airing Facebook’s dirty laundry, and the stock keeps falling as a result.

The FDA put a clinical hold on one of the biotech’s new drug candidates.

A clinical trial with an experimental lung cancer drug produced some positive results.

LOVE earnings call for the period ending June 30, 2021.